302 related articles for article (PubMed ID: 2840081)
21. Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes.
Bremm KD; König W; Pfeiffer P; Rauschen I; Theobald K; Thelestam M; Alouf JE
Infect Immun; 1985 Dec; 50(3):844-51. PubMed ID: 2866160
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of leukotriene formation in human leukocytes by halothane.
Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S
Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P
J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257).
Sun FF; McGuire JC
Prostaglandins; 1983 Aug; 26(2):211-21. PubMed ID: 6417727
[TBL] [Abstract][Full Text] [Related]
25. Regional distribution of lipoxygenase activities in porcine ciliary epithelium.
Sakamoto S; Shichi H
J Ocul Pharmacol; 1991; 7(2):141-5. PubMed ID: 1655933
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: evidence for the involvement of lipoxygenase products in steroidogenesis.
Dix CJ; Habberfield AD; Sullivan MH; Cooke BA
Biochem J; 1984 Apr; 219(2):529-37. PubMed ID: 6430271
[TBL] [Abstract][Full Text] [Related]
27. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo.
Beetens JR; Loots W; Somers Y; Coene MC; De Clerck F
Biochem Pharmacol; 1986 Mar; 35(6):883-91. PubMed ID: 3006695
[TBL] [Abstract][Full Text] [Related]
28. Development of a system for evaluating 5-lipoxygenase inhibitors using human whole blood.
Sweeney FJ; Eskra JD; Carty TJ
Prostaglandins Leukot Med; 1987 Jun; 28(1):73-93. PubMed ID: 3039537
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of arachidonate lipoxygenase activities by 2-(3,4-dihydroxyphenyl)ethanol, a phenolic compound from olives.
Kohyama N; Nagata T; Fujimoto S; Sekiya K
Biosci Biotechnol Biochem; 1997 Feb; 61(2):347-50. PubMed ID: 9058975
[TBL] [Abstract][Full Text] [Related]
30. Products of the lipoxygenase pathway in human natural killer cell cytotoxicity.
Rossi P; Lindgren JA; Kullman C; Jondal M
Cell Immunol; 1985 Jun; 93(1):1-8. PubMed ID: 2986854
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene synthesis by human gastrointestinal tissues.
Dreyling KW; Hoppe U; Peskar BA; Morgenroth K; Kozuschek W; Peskar BM
Biochim Biophys Acta; 1986 Sep; 878(2):184-93. PubMed ID: 3019409
[TBL] [Abstract][Full Text] [Related]
32. Effect of AA-861, a 5-lipoxygenase inhibitor, on leukotriene synthesis in human polymorphonuclear leukocytes and on cyclooxygenase and 12-lipoxygenase activities in human platelets.
Mita H; Yui Y; Shida T
Allergy; 1986 Sep; 41(7):493-8. PubMed ID: 3024521
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of leukotriene B4 (LTB4) in human neutrophils by L-threo-dihydrosphingosine.
Darges JW; Robinson SP; Adams LM
Adv Exp Med Biol; 1997; 400A():387-92. PubMed ID: 9547581
[TBL] [Abstract][Full Text] [Related]
34. L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor.
Guindon Y; Girard Y; Maycock A; Ford-Hutchinson AW; Atkinson JG; Bélanger PC; Dallob A; DeSousa D; Dougherty H; Egan R
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():554-7. PubMed ID: 2821766
[No Abstract] [Full Text] [Related]
35. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Schröder JM
J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
[TBL] [Abstract][Full Text] [Related]
36. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of 5-lipoxygenase activity in polymorphonuclear leukocytes of rats by caseinate treatment.
Chang WC; Su GW
Biochem Pharmacol; 1987 Sep; 36(18):3033-6. PubMed ID: 2820429
[TBL] [Abstract][Full Text] [Related]
38. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
Foster SJ; Bruneau P; Walker ER; McMillan RM
Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
[TBL] [Abstract][Full Text] [Related]
39. Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.
Honda Z; Iizasa T; Morita Y; Matsuta K; Nishida Y; Miyamoto T
Biochem Pharmacol; 1987 May; 36(9):1475-81. PubMed ID: 3034290
[TBL] [Abstract][Full Text] [Related]
40. Effect of inhibition of 5-lipoxygenase metabolism of arachidonic acid on response to endotoxemia in sheep.
Coggeshall JW; Christman BW; Lefferts PL; Serafin WE; Blair IA; Butterfield MJ; Snapper JR
J Appl Physiol (1985); 1988 Sep; 65(3):1351-9. PubMed ID: 2846494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
